Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis DiseaseAmita Gupta, Susan Swindells, Soyeon Kim, et al.
The Lancet. Respiratory Medicine|April 23, 2026
Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trialAnnelies Van Rie, Emilyn Costa Conceição, Felex Ndebele, et al.
The Lancet. Infectious Diseases|January 20, 2017
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trialMartin J Boeree, Norbert Heinrich, Rob Aarnoutse, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Inflammatory Biomarkers of Asymptomatic and Symptomatic TuberculosisDenis Awany, Dominique T Ariefdien, Simon C Mendelsohn, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2021
Longitudinal Dynamics of a Blood Transcriptomic Signature of TuberculosisHumphrey Mulenga, Munyaradzi Musvosvi, Simon C Mendelsohn, et al.
The Lancet. Infectious Diseases|March 8, 2025
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trialÁlvaro H Borges, Marisa Russell, Dereck Tait, et al.
The Lancet. Microbe|December 22, 2024
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant dataPuck T Pelzer, Logan Stuck, Leonardo Martinez, et al.
Science (New York, N.Y.)|August 1, 2015
HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodiesWilton B Williams, Hua-Xin Liao, M Anthony Moody, et al.
Bulletin of the World Health Organization|July 29, 2024
Target regimen profiles for tuberculosis treatmentChristian Lienhardt, Kelly E Dooley, Payam Nahid, et al.
Pageof 14